Join the Alzheimer's Disease group to help and get support from people like you.
Alzheimer's Disease News (Page 11)
Related terms: Presenile Dementia, SDAT, Senile dementia Alzheimer's Type, Alzheimers
Adverse Brain Health Outcomes Increased for Sexual, Gender Minority Groups
FRIDAY, Sept. 27, 2024 – Sexual and gender-minority (SGM) persons have increased odds of adverse brain health outcomes, according to a study published online Sept. 25 in Neurology. Shufan Huo, M.D.,...
Greater Adherence to MIND Diet Linked to Reduced Cognitive Impairment
WEDNESDAY, Sept. 18, 2024 – Greater Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet adherence is associated with a reduced risk for...
SGLT2i Use Linked to Lower Risk for Neurodegenerative Disease in T2DM
WEDNESDAY, Sept. 18, 2024 – For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced risks for incident dementia and Parkinson disease...
Cognitively Stimulating Leisure Activity Protects From Further Cognitive Decline
THURSDAY, Sept. 19, 2024 – High levels of cognitively stimulating leisure activity (CSLA) in older adults with mild cognitive impairment (MCI) can slow further decline, according to a study recently...
Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's
THURSDAY, Sept. 19, 2024 – A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inh...
Could 'Brain Training' Exercises Help Slow Alzheimer's Symptoms?
TUESDAY, Sept. 17, 2024 – Brain training aimed at improving memory can ward off symptoms of Alzheimer’s disease for years, a new study claims. Seniors experienced a slower decline in their memory a...
Alzheimer's Drugs May Work in Whole New Way, Study Finds
THURSDAY, Sept. 11, 2024 – Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug Administration...
Vision Impairment Contributes to Dementia Risk
WEDNESDAY, Sept. 11, 2024 – The population-attributable fraction of dementia from vision impairments ranges from 4.9 to 19.0 percent, according to a study published online Sept. 5 in JAMA ...
Falling for Financial Scams Could Be Early Alzheimer's Sign
TUESDAY, Sept. 10, 2024 – Brain changes that signal Alzheimer's disease even before symptoms appear are linked to an increased vulnerability to financial scams, new research shows. “Assessing f...
Diabetes, Prediabetes Tied to Accelerated Brain Aging
TUESDAY, Sept. 10, 2024 – Diabetes and prediabetes are associated with accelerated brain aging and potential dementia, according to a study published online Aug. 28 in Diabetes Care. Abigail Dove, ...
Outdoor Nighttime Light Exposure Linked to Prevalence of Alzheimer Disease
FRIDAY, Sept. 6, 2024 – Exposure to outdoor nighttime light is associated with the prevalence of Alzheimer disease (AD), especially among those aged younger than 65 years, according to a study...
Too Much Light at Night Linked to Higher Alzheimer's Risk
FRIDAY, Sept. 6, 2024 – People who live in areas with more nighttime light pollution could be at increased risk of Alzheimer’s disease, particularly those in middle age, a new study says. Nightly l...
Urinary Cadmium Levels Linked to Cognitive Impairment in Whites
WEDNESDAY, Sept. 4, 2024 – Among White, but not Black individuals, urinary cadmium (Cd) concentrations are associated with cognitive impairment, according to a study published online Sept. 4 in...
Dementia Diagnoses Up in Individuals With Acute Kidney Injury
THURSDAY, Sept. 5, 2024 – Individuals with acute kidney injury (AKI) have an increased risk for receiving a clinical diagnosis of dementia, according to a study published online Aug. 22 in...
SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes
TUESDAY, Sept. 3, 2024 – Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in The BMJ. Anna ...